Fresenius Kabi is a global healthcare company with broad capabilities in Pharma, Nutrition, MedTech, and BioPharma and deep specialization in the essential products medical professionals depend on to provide lifesaving and life-sustaining care to patients with critical and chronic conditions. The vast majority of these are used by clinicians in acute care hospitals, infusion centers, oncology clinics, and similar care sites — but a significant number support specialized activities in facilities like R&D labs and blood and plasma centers. Worldwide, Fresenius Kabi operates in more than 70 locations in 50 countries. Its corporate headquarters is in Bad Homburg, Germany. Its US headquarters is in Lake Zurich, Illinois. In the US, Fresenius Kabi offers leading portfolios in the following sub-categories: 𝐏𝐡𝐚𝐫𝐦𝐚: Injectable Medicines (Oncology, Anesthesia & Analgesia, Anti-Infectives, Critical Care) and IV Solutions 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧: Parenteral Nutrition 𝐌𝐞𝐝𝐓𝐞𝐜𝐡: Infusion Technologies, Blood Technologies, Cell & Gene Technologies, and Plasma Technologies 𝐁𝐢𝐨𝐏𝐡𝐚𝐫𝐦𝐚: Biosimilars (Oncology and Immunology)